Progenics Pharmaceuticals Inc
PGNX
PGNX was delisted on the 19th of June, 2020.
133 hedge funds and large institutions have $386M invested in Progenics Pharmaceuticals Inc in 2015 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 43 increasing their positions, 43 reducing their positions, and 12 closing their positions.
100% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 12
29% more call options, than puts
Call options by funds: $1.14M | Put options by funds: $886K
10% more funds holding
Funds holding: 121 → 133 (+12)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 43
23% less capital invested
Capital invested by funds: $501M → $386M (-$115M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$6.06M |
| 2 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$3.23M |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$3.05M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$2.55M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.43M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$6.12M |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$6M |
| 3 |
State Street
Boston,
Massachusetts
|
-$3.4M |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.9M |
| 5 |
RA
Royce & Associates
New York
|
-$1.86M |
PGNX Hedge Fund Activity: Q3 2015 in Review
133 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Progenics Pharmaceuticals Inc (PGNX) for Q3 2015, worth a combined $386M — down 23% from $501M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new PGNX positions and 12 closed out — a net gain of 12 holders — while 43 added to existing stakes and 43 trimmed.
The largest buyer was Bogle Investment Management, opening a new position worth an estimated $6.06M. The largest seller was Wellington Management Group, cutting an estimated $6.12M.
- 133 institutional investors held Progenics Pharmaceuticals Inc (PGNX) as of Q3 2015, up from 121 in Q2 2015.
- Funds reported $386M of Progenics Pharmaceuticals Inc stock for Q3 2015, down 23% quarter-over-quarter.
- 24 funds opened new Progenics Pharmaceuticals Inc positions in Q3 2015 and 12 closed out, a net change of +12 holders.
- The largest Progenics Pharmaceuticals Inc buyer in Q3 2015 was Bogle Investment Management, an estimated $6.06M added.
- The largest Progenics Pharmaceuticals Inc seller in Q3 2015 was Wellington Management Group, an estimated $6.12M sold.
Based on aggregated 13F filings for Q3 2015.